Physicians and qualified clinical investigators apply through hyJournal’s existing collaboration intake. Investigator activation and study readiness are reviewed before any study workflow is opened.
Your DNA contains the blueprint for how your body handles inflammation, repair, energy, and aging. GeneOS reads that blueprint — and turns it into a precise, personalized protocol. For you. For your patients.
One-time payment · Lifetime access · No subscription ever · Encrypted results delivered by our certified lab
GeneOS analyzes 18,000+ of your gene variants — how you metabolize nutrients, handle inflammation, respond to peptides, manage stress, and age. Then Hypatia AI builds you a personalized 12-week protocol. One test. For life.
Kit ships in 3–5 days · Results in ~3 weeks from lab receipt · No subscription required now or ever
GeneOS supports a clinician-led pilot pathway for practices that want structured DNA/RNA provenance, defined longitudinal marker packages, and an authorized hyJournal research handoff. This public entry point is for recruitment and kit access; it does not promise outcomes, activate a study, or replace investigator review.
Physicians and qualified clinical investigators apply through hyJournal’s existing collaboration intake. Investigator activation and study readiness are reviewed before any study workflow is opened.
GeneOS keeps kit, laboratory, and DNA/RNA provenance in its own token-scoped workflow. Any approved research handoff uses an opaque study reference — never a public identity, raw token, or raw DNA/RNA file.
The Lab Team helps organize evidence, marker definitions, QC context, and review boundaries. It does not convert a marker package into a promised clinical outcome or bypass protocol approval.
The PILOT offer is validated by the GeneOS server at checkout; the public page does not calculate or grant pricing. Research participation requires the authorized workflow and appropriate review.
Most AI in health is a chatbot in a lab coat. GeneOS is something else entirely — a structured clinical-intelligence workflow that pairs a coordinated evidence team with source-linked genomic, biomarker, and safety review.
Underneath the premium language, it’s still broad-spectrum decision-making pretending to be customization. The ingredients change. The guesswork doesn’t.
“Personalized” protocols built on population averages and trend-driven ingredient selection, dressed up in clinical-sounding language. It looks sophisticated. It isn’t.
“Underneath the premium language, it’s still broad-spectrum decision-making pretending to be customization.”
Protocol design that starts with allelic configuration — the specific gene variants shaping how each patient handles inflammation, repair, energy, detox, and recovery. Once you can see the wiring, you stop guessing.
Each pillar builds on the last. Together, they give your clinical team a line from biology to intervention that no other platform can draw.
The specific gene variants that define how each patient handles inflammation, repair, energy production, detoxification, and recovery. Once you can see the wiring, protocol design stops being guesswork and starts becoming intelligent architecture.
→ 18,000+ variants mapped per patientFull exosome sequencing captures cellular signaling in real time — how the body is communicating now, where recovery is stalling, and which interventions fit the current biology. Predisposition tells you the potential. Exosome data tells you the present state. GeneOS accepts BAM, CRAM, FASTQ, and RNA-seq files directly — including targeted ribosome expression panels — and automatically scores pathway and pillar activation.
→ BAM · CRAM · FASTQ · RNA-seq · Ribosome ExpressionStructured, usable patient blueprints your clinical team can act on immediately. No bloated data dump. No science fair report. Just clear direction — organized by pathway, priority, and intervention window.
→ Delivered in <48 hoursIdentify the inputs most likely to activate the pathways tied to performance, resilience, tissue repair, metabolic efficiency, and stress adaptation. See what the patient is wired toward and what their system is primed to respond to right now.
→ Pathway activation targetingBespoke peptide stacks aligned to molecular need, not broad-spectrum guessing. Targeted intervention design built from the allelic and exosome profile. Tighter protocols, faster refinement, sharper outcomes.
→ Molecular-targeted, not trend-basedDelivery architecture matched to the intervention targets identified in the molecular profile. Every component has a biological reason. Every stack is a clinical decision, not a product bundle.
→ Delivery matched to molecular targetsFive clinical stages. Zero guesswork. Every decision grounded in that patient’s biology.
Collect genetics, baseline labs, health history. Order a GeneOS kit or upload existing genomic data — including BAM/FASTQ files from prior sequencing runs.
Hypatia AI processes the full biological dataset — gene variants and real-time cellular signaling together.
Structured report delivered to your clinical team in under 48 hours. Clear, actionable, zero noise.
Peptide matrix + smart patch stack designed precisely to the molecular profile. Not a standard stack.
Ongoing exosome tracking and protocol optimization. The protocol adapts as the biology responds.
Generic chat tools predict the next plausible sentence. They do not normalize a patient record, enforce evidence eligibility, reconcile variants against active medications and biomarkers, or leave a source-linked decision trail. That is how a polished answer becomes a clinical horoscope.
A general-purpose chatbot can summarize a paper or generate a plausible protocol. It cannot reliably establish whether that output applies to this patient, this phenotype, this medication list, or this lab state.
GeneOS builds the assessment first. Hypatia then explains a structured result that has already been constrained by the patient’s genomic, biomarker, medication, condition, and intervention context.
GeneOS provides your clinical team with the complete DNA + ribosome expression kit, in-house lab processing, and the AI platform to turn raw genomic data into patient-specific interventions. No guesswork. No generic stacks. Clear molecular direction for every patient.
We supply the full DNA + ribosome expression collection kit directly to you or your patients. Our lab processes every sample and delivers encrypted results to your clinical dashboard — no third-party lab coordination required.
Review medication, phenotype, biomarker, and pharmacogenomic context together. GeneOS surfaces relevant safety and evidence signals for clinical review rather than producing a generic dosing instruction.
New genomic research changes what variants mean clinically — every day. Hypatia absorbs new studies automatically so your protocols reflect the current science, not last year’s textbook.
Every clinical subscription includes full API access. Connect GeneOS directly into your EHR, CRM, or practice management system — pull your entire token vault, manage patient tokens, and trigger webhooks on results-ready events. No extra cost, no integration fees.
Kit pricing, volume discounts, and platform access are tailored to your practice size. Let’s talk about what that looks like for your team.
📅 Request a Clinical Meeting →The following illustrative journeys show the type of questions GeneOS organizes for review. They are not clinical outcomes or guarantees.
“An evidence-aware review can turn a long list of variants, labs, and health history into questions worth taking to a clinician or care team. The point is not a generic stack. It is understanding which findings are actionable, which need more context, and which should not be overclaimed.”Illustrative metabolic-health journey Biohacker · Austin, TX Illustrative profile · evidence review example
“A strong genomic review separates what is scoreable, what is recommendation context, and what is safety context. That makes the next conversation more specific: which lab to repeat, which active medication matters, and which assumption should be tested instead of guessed.”Illustrative genomic-review journey Health Optimizer · Denver, CO Illustrative profile · evidence review example
“We spent years thinking we were doing personalized medicine. We weren’t. GeneOS showed us what it actually looks like when you can see a patient’s allelic wiring before you design a protocol. Our retention numbers haven’t been the same since.”Dr. Nathan Kessler, MD Regenerative Medicine & Performance Kessler Performance Health — Denver, CO
“The exosome sequencing layer changed how I think about intervention timing entirely. Predisposition tells you what might happen. Real-time signaling tells you what’s happening right now. That gap is where most clinics lose the patient — and where GeneOS gives you the edge.”Dr. Jennifer Holloway, MD, PhD Functional & Precision Medicine Holloway Biomarker Institute — San Francisco, CA
“My team stopped guessing. That’s the simplest way I can put it. We get a blueprint, we build to it, we track the exosome response, and we refine. The protocols are tighter, the outcomes are sharper, and patients feel the difference.”Dr. Sarah Winthrop, MD Integrative & Longevity Medicine Winthrop Longevity Partners — Austin, TX
The world’s best genomics clinician would need to hold 35 million peer-reviewed papers, 200 million AlphaFold protein structure predictions, decades of Russian peptide institute research that never made it into Western journals, and 18,000+ gene-to-pathway associations — in their head, simultaneously, for every patient. Then update it every day as new science rewrites what variants mean clinically.
No human can do that. Hypatia does. And when a new study changes the clinical picture for a variant your patients carry, every protocol that variant touches updates automatically.
13 evidence specialists · 7 core · 6 on-demand
The core team is always available for genetics, variants, pathways, biomarkers, gene history, peptides, and protocol design. Domain specialists join when pharmacogenomics, nutrition, immunogenetics, statistics, toxicology, or rare-disease curation is relevant.
GeneOS is loading the canonical specialist roster.
GeneOS normalizes and cross-references evidence from clinical, genomic, pharmacogenomic, and literature systems before it reaches a blueprint.
Source systems are queried or referenced where clinically applicable. Their names identify evidence and analysis inputs, not endorsements or commercial affiliation.
Follow a clearly labeled synthetic profile through token privacy, guided intake, an evidence-aware health account, and a patient-controlled report prompt.
🧬 Launch Interactive Demo →No account required · Synthetic walkthrough in under 3 minutes
The updated demo follows the same product sequence as GeneOS: token privacy, guided intake, evidence-aware variants and biomarkers, health-account progress, then an optional report handoff.
Individuals get lifetime access for a single one-time payment. Clinical practices get custom kit pricing and platform access tailored to their patient volume — contact us to build the right package.
Ships in 3–5 days · Results in ~3 weeks from lab receipt
Clinical pricing is based on your practice size, kit volume, and platform needs. We build a package that fits — no forcing a subscription that doesn’t match your patient load.
Kit volume, platform access, and pricing tailored to your practice. No call centre — you meet directly with our team.
💬 Request a Clinical MeetingNot sure which is right for you? If you want to understand your own DNA — order the individual kit. If you run a practice and want to offer genetic precision to your patients — reach out and we’ll put together the right clinical package. Questions?
Watch how GeneOS transforms a patient intake into a precision intervention. No guesswork. No generic stacks. Just clear biological direction.
Approved partners earn a 10% direct-sales commission on eligible, paid GeneOS kit orders. We provide referral links, factual privacy-forward assets, and a unified partner workspace.
Share a direct DNA-kit referral link with people looking for a privacy-forward genomic workflow. The kit is a one-time purchase with lifetime GeneOS access.
10% on eligible paid direct kit salesIntroduce qualified practices to clinical bulk-kit purchasing, Token Vault operations, and the GeneOS platform. Final clinical pricing and fulfillment stay with GeneOS.
Referral attribution is recorded before payment reviewPartners receive factual flyers, video concepts, campaign copy, price references, and presence links. Every promotional asset requires review, affiliate disclosure, and claims-safe language.
Privacy claims and clinical statements are evidence-reviewedMeet with our clinical team to see how GeneOS maps to your patient workflow. No sales pitch — just the platform, live, on your timeline. We’ll assign the right team member based on availability.